40
Views
0
CrossRef citations to date
0
Altmetric
Original Article

Midkine Expression in Reed-Sternberg Cells of Hodgkin's Disease

, , , , , , , , , , , , & show all
Pages 415-424 | Accepted 05 Sep 1999, Published online: 01 Jul 2009

References

  • Kadomatsu Tomomura K. M., Muramatsu T. cDNA cloning and sequencing of a new gene intensely expressed in early differentiation stages of embryonal carcinoma cells and in mid-gestation period of mouse embryogenesis. Biochemical and Biophysical Research Communication 1988; 151: 1312–1318
  • Kaname Kuwano T., Murano A., Uehara I., Muramatsu K. T., Kajii T. Midkine gene (MDK), a gene for prenatal differentiation and neuroregulation, maps to band 11p11.2 by fluorescence in situ hybridization. Genetics 1993; 17: 514–515
  • Tomomura Kadomatsu M., Matsubara K. S., Muramatsu T. A retinoic acid-responsive gene, MK, found in the terato-carcinoma system. Heterogeneity of the transcript and the nature of the translation product. Journal of Biological Chemistry 1990; 265: 10765–10770
  • Kadomatsu Haung K., Suganuma R-P., Murata T. F., Muramatsu T. A retinoic acid responsive gene MK found in the teratocarcinoma system is expressed in specially and temporally controlled manner during mouse embryogenesis. Journal of Cell Biology 1990; 110: 607–616
  • Tsutsui Kadomatsu J., Matsubara K., Nakagawara S., Hamanoue A., Takao M., Ohi S. Y., Muramatsu T. A new family of heparin-binding growth / differentiation factors: increased midkine expression in Wilms tumor and other human carcinomas. Cancer Research 1993; 53: 1281–1285
  • Uehara Matsubara K., Kadomatsu S., Tsutsui K. J., Muramatsu T. Genomic structure of human midkine (MK), a retinoic acid-responsive growth/differentiation factor. Journal of Biochemistry (Tokyo). 1992; 111: 563–567
  • Yoshida Y, Goto Tsutsui M., Ozawa J. M., Sato Osame E. M., Muramatsu T. Midkine is present in the early stage of cerebral infarct. Developmental Brain Research 1995; 85: 25–30
  • Chauhan Li A. K.Y.S., Deuel T. F. Pleiotrophin transforms NIH 3T3 cells and induces tumors in nude mice. Proceedings of the Natlional Academy of Science in USA 1993; 90: 679–682
  • Muramatsu Shirahama H., Yonezawa H., Murata S. H., Muramatsu T. Midkine, a retinoic-acid inducible growth/differentiation factor: immunochemical evidence for the function and distribution. Developmental Biology 1993; 159: 392–402
  • Kadomatsu Hagihara K., Akhter M., Fan S., Muramatsu Q-W. H., Muramatsu T. Midkine induces the transformation of NIH3T3 cells. British Journal of Cancer 1997; 75: 354–359
  • Garver R. I., Jr., Chan C., Milner P. G. Reciprocal expression of pleiotrophin and midkine in normal versus malignant lung tissues. American Journla of Respiratory Cell and Molecular Biology 1993; 9: 463–466
  • Garver R I, Jr., Radfold D, Donis-Keller M., Wick H. M. R., Milner P. Midkine and pleiotrophin expression in normal and malignant breast tissue. Cancer 1994; 74: 1584–1590
  • Aridome Tsutsui K., Takao J., Kadomatsu S., Ozawa K., Aikou M. T., Muramatsu T. Increased Midkine gene expression in human gastrointestinal cancers. Japanese Journal of Cancer Research 1995; 86: 655–661
  • Miyauchi Shimada M., Kadomatsu H., Muramatsu K., Matsubara T., Ikematsu S., Takenaga S. K., Asano Ochiai T., Sakiyama T. S., Tagawa M. Frequent expression of midkine gene in esophageal cancer suggests a potential usage of its promoter for suicide gene therapy. Japanese Journal of Cancer Research 1999; 90: 469–475
  • Nakagawara Milbrandt A., Muramatsu J., Deuel T. T., Zhao F., Cnaan H. A., Brodeur G. M. Differntial expression of Pleiotropin and Midkine in advanced neuroblastomas. Cancer Research 1995; 55: 1792–1787
  • O'Brien David T., Susan C., Roy F. B., Adrian L. H. The angiogenic factor Midkine is expressed in bladder cancer, and overexpression correlates with a poor outcome in patients with invasive cancers. Cancer Research 1996; 56: 2515–2518
  • Ohnishi Ichikawa K., Kagami A., Nagasaka Y., Niwa T., Hotta T. T., Saito H. Interleukin 4 and γ-interferon may play a role in the histopathogenesis of peripheral T cell lymphoma. Cancer Research 1990; 50: 8028–8033
  • Kato Nagasaka H., Ichikawa T., Kinoshita A., Murate T., Tsushita T., Hotta K. T., Saito H. Tumor necrosis factor-β gene expression and its relationship to the clinical features and histopathogenesis of peripheral T-cell lymphomas. Leukemia and Lymphoma. 1994; 16: 125–133
  • Kato Kinoshita H., Suzuki T., Nagasaka S., Murate T., Saito T. H., Hotta T. Elevated serum interleukin-6 (IL-6) is derived from neoplastic lymphoid cells in patients with B-cell non-Hodgkin's lymphoma: correlation with extent of IL-6 expression and serum concentration. British Journal of Haematology 1996; 92: 1014–1021
  • Harris Jaffe N. L., Stein E. S., Banks H., Chan P. M., Clearly J. K., Delsol M. L., De G., Wolf-Peeters C., Falini Gatter B., Grogan K. C., Isaacson T. M., Knowles P. G., Mason D. M., Muller- D. Y., Hermelink Pileri H. K., Piris S. A., Ralfkiaer M. A. E., Warnke R. A. A revised European-American classification of lymphoid neoplasms: A proposal from the international lymphoma study group. Blood 1994; 84: 1361–1392
  • Muramatsu H., Muramatsu T. Purification of recombinant midkine and examination of its biological activites: functional comparison of new heparin binding factors. Biochemical and Biophysical Research Communication 1991; 177: 652–658
  • Ewins Barnett D. L., Tomlinson P. S., Mc W. S., Gregor A. M., Banga J. P. Mapping epitope specificities of monoclonal antibodies to thyroid preoxidase using recombinant antigen preparations. Autoimmunity 1992; 11: 141–149
  • Murate Yamashita T., Isogai K., Suzuki C., Ichihara H., Hatano M., Nakahara S., Kinoshita Y., Nagasaka T., Yoshida T., Komatsu S., Miura N., Hotta Y., Fujimoto T., Saito N. H., Hayakawa T. The production of tissue inhibitor of metalloproteinases (TIMPs) in megakaryopoiesis: possible role of platelet- and megakaryocyte-derived TIMPs in bone marrow fibrosis. British Journal of Haematology 1997; 99: 181–189
  • Mori Watanabe N., Yamashita K., Nakayama Y., Yatabe A., Narita Y., Kobayashi M., Hasegawa T., Kojima Y. H., Nagasawa T. Hodgkin Disease with subsequent transformation to CD30 positive non-Hodgkin lymphoma in six patients. Cancer 1999; 85: 970–979
  • Chomezynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocynate-phenol chloroform extraction. Analytical Biochemistry 1987; 62: 156–159
  • Hsu S-Xie M. S-S., Waldron J. A., Jr. Functional heterogeneity and pathologic significance of interleukin-6 in B-cell lymphomas. American Journal of Pathology 1992; 141: 915–923
  • Ohno Stribley T., Wu J. A., Hinrich G., Weisenberg S. H.D.C., Chan W. C. Clonality in nodular lymphocyte-predominanr Hodgkin's disease. New England Journal of Medicine 1997; 337: 459–465
  • Vockerodt Soares M., Kanzler M., Kuppers H., Kube R., Hansmann D., Diehl M. L. V., Tesch H. Detection of clonal Hodgkin and Reed-Sternberg cells with identical somatically mutated and rearranged VH genes in different biopsies in relapsed Hodgkin's disease. Blood 1998; 92: 2899–2907
  • Enblad Sandvej G., Lennette K., Sundstrom E., Klein C., Glimelius G. B., Pallesen G. Lack of correlation between EBV serology and presence of EBV in the Hodgkni and Reed-Sternberg cells of patients with Hodgkin's disease. International Journal of Cancer 1997; 72: 394–397
  • Herbst H. Ebstein-Barr virus in Hodgkin's disease. Seminar in Cancer Biology 1996; 7: 183–189
  • Drexler H G. Recent results on the biology of Hodgikin and Reed-Sternberg cells. I, Biopsy material. Leukemia and Lymphoma. 1992; 8: 283–313
  • Xerri Birg L., Guigou F., Bouabdallah V., Poizot R. MI., Hassoun J. In situ expression of the IL-1 alpha and TNF-alpha genes by Reed-Sternberg cells in Hodgkin disease. International Journal of Cancer 1992; 50: 689–693

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.